Product Code: 2417
The embolic protection devices market is expected to garner substantial revenue by 2030 owing to the rise in aging population. In addition, unhealthy lifestyle choices causing severe diseases, along with growing demand for minimally invasive procedures, are also likely to proliferate industry growth through the forecast timespan.
During the COVID-19 pandemic, the industry witnessed a negative impact due to declining cases of PCI procedures and disruptions in supply chains. However, in the post-pandemic scenario, the industry saw a surge in product penetration backed by improving standards of living.
Moreover, key market players have been mainly focusing on product range expansion and increasing production capacity to improve their deployment operations and strengthen their business standing. In order to cater to prevalent customer needs, manufacturers are also developing innovative and cost-effective products, which has been favorable for overall market expansion.
The embolic protection devices market has been categorized based on product, application, material, end-use, and region.
In terms of product, the industry has been segregated into proximal occlusion systems, distal occlusion systems, and distal filters. The distal filters segment is slated to grow massively through the review timeline as a result of beneficial features of these filters, such as trapping large debris and maintaining the flow of blood, as compared to their counterparts. Subsequently, escalating utilization of these filters in several procedures is primed to promote segmental uptake.
With respect to application, the embolic protection devices market has been classified into neurovascular disease, cardiovascular disease, and peripheral disease. The neurovascular disease segment held a prominent market share in 2021 and is foreseen to observe sizable development over the estimated period. The growth of the segment can be credited to the expanding geriatric population base and surging demand for the treatment of various neurological disorders.
The industry has been segmented on the basis of end-use into ambulatory surgical centers, hospitals, and others. Among these, the hospitals segment is set to amass considerable gains in the forthcoming years on account of the easy availability of technologically advanced medical devices and skilled healthcare professionals in hospitals.
Regionally, the Latin America embolic protection devices market is speculated to depict a CAGR of over 8.4% through the projected timeline due to snowballing adoption of these devices for minimally invasive procedures, such as saphenous vein graft (SVG) interventions as well as carotid artery stenting procedures, in the LATAM region.
Meanwhile, the Middle East & Africa embolic protection devices industry valuation was recorded at around $63.6 million in 2021 and is forecast to register strong progress over 2022-2030. The burgeoning prevalence of unhealthy and sedentary lifestyles is anticipated to stimulate MEA market growth.
Table of Contents
Chapter 1 Methodology
- 1.1 Methodology
- 1.2 Market definition
- 1.3 Forecast parameters
- 1.3.1 North America
- 1.3.2 Europe
- 1.3.3 Asia Pacific
- 1.3.4 Latin America
- 1.3.5 Middle East & Africa
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Embolic protection devices market industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 Material trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends
Chapter 3 Embolic Protection Devices Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Growing preference for minimally invasive procedures
- 3.3.1.2 Increasing prevalence of cardiovascular diseases in developed countries
- 3.3.1.3 Favorable reimbursement scenario in North America
- 3.3.1.4 Technological advancement in embolic protection devices
- 3.3.1.5 Growing geriatric population in developing countries
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Availability of alternatives
- 3.3.2.2 Stringent regulatory framework
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.4.3 By material
- 3.4.4 By end-use
- 3.4.5 Regulatory landscape
- 3.5 COVID-19 impact analysis
- 3.6 Porter's analysis
- 3.6.1 Bargaining power of suppliers
- 3.6.2 Bargaining power of suppliers
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
- 3.7 Competitive landscape, 2021
- 3.7.1 Company matrix analysis
- 3.7.2 Supply chain analysis
- 3.7.2.1 Raw material suppliers
- 3.7.2.2 Manufacturers
- 3.7.2.3 Distribution channel analysis
- 3.7.2.4 End-users
- 3.8 PESTEL analysis
- 3.8.1 Political
- 3.8.2 Economic
- 3.8.3 Social
- 3.8.4 Technological
- 3.8.5 Environmental
- 3.8.6 Legal
Chapter 4 Embolic Protection Devices Market, By Product
- 4.1 Key segment trends
- 4.2 Distal occlusion systems
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Proximal occlusion systems
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4 Distal filters
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Embolic Protection Devices Market, By Application
- 5.1 Key segment trends
- 5.2 Cardiovascular disease
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Neurovascular disease
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.4 Peripheral disease
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Embolic Protection Devices Market, By Material
- 6.1 Key segment trends
- 6.2 Nitinol
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Polyurethane
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Embolic protection devices Market, By End-use
- 7.1 Key segment trends
- 7.2 Hospitals
- 7.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.3 Ambulatory surgical centers
- 7.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.4 Others
- 7.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Embolic Protection Devices Market, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.4 Market size, by material, 2017 - 2030 (USD Million)
- 8.2.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.2.6 U.S.
- 8.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.6.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.2.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.2.7 Canada
- 8.2.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.7.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.2.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.4 Market size, by material, 2017 - 2030 (USD Million)
- 8.3.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.6 Germany
- 8.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.6.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.3.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.7 UK
- 8.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.7.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.3.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.8 France
- 8.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.8.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.3.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.9 Italy
- 8.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.9.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.3.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.10 Spain
- 8.3.10.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.10.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.10.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.3.10.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.4 Market size, by material, 2017 - 2030 (USD Million)
- 8.4.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.6 China
- 8.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.6.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.4.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.7 Japan
- 8.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.7.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.4.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.8 India
- 8.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.8.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.4.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.9 Australia
- 8.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.9.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.4.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.4 Market size, by material, 2017 - 2030 (USD Million)
- 8.5.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5.6 Brazil
- 8.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.6.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.5.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5.7 Mexico
- 8.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.7.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.5.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6 MEA
- 8.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.4 Market size, by material, 2017 - 2030 (USD Million)
- 8.6.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.6 South Africa
- 8.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.6.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.6.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.7 Saudi Arabia
- 8.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.7.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.6.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.8 UAE
- 8.6.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.8.3 Market size, by material, 2017 - 2030 (USD Million)
- 8.6.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
- 9.1 Competitive dashboard
- 9.2 Abbott Laboratories
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
- 9.3 Allium Medica
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
- 9.4 Boston Scientific Corporation
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
- 9.5 Cardinal Health
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
- 9.6 Contego Medical, LLC
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
- 9.7 Edwards Lifesciences Corporation
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
- 9.8 W. L. Gore & Associates (Gore Medical)
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
- 9.9 Innovative Cardiovascular Solutions, LLC
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
- 9.10 Keystone Heart
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
- 9.11 Medtronic
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
- 9.12 Metactive Medical
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis
- 9.13 Transverse Medical, Inc.
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 SWOT analysis